Skip to main content
. 2019 Sep 20;12(4):141. doi: 10.3390/ph12040141

Table 1.

Selected outcomes reported in the two datasets; all adverse event (AE) cases considered per cohort. Note that the outcomes associated to a single event may be more than one.

Outcome % Zevalin AEs % Bexxar AEs
FAERS VigiBase FAERS VigiBase
Death 33.4 22.8 22.1 24.1
Hospitalization 41.5 22.1 31.0 20.5
Life threatening 7.4 3.9 7.9 5.2
Other 46.3 31.8 36.6 23.1